Clinical trial
Hypofractionated Radiation Fractionation in Breast Cancer Patients With Implant-Based Reconstruction
NCT06830083 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hypofractionated Radiation Fractionation in Breast Cancer Patients With Implant-Based Reconstruction
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 30, 2025
- Completion date
- December 31, 2033
- Enrollment
- 840 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer